Filter
7989
Filtered Results: 7989
Text search:
Health
and
Human
Rights
Info
Featured
Recommendations
734
New Publications
2042
Language
Document type
No document type
4463
Studies & Reports
1363
Guidelines
966
Manuals
463
Strategic & Response Plan
313
Fact sheets
156
Training Material
140
Situation Updates
64
Brochures
21
Infographics
20
Resource Platforms
12
Online Courses
6
App
1
Videos
1
Countries / Regions
Global
355
India
270
Kenya
233
South Africa
156
Ethiopia
154
Nepal
149
Sierra Leone
149
Nigeria
146
Western and Central Europe
138
Uganda
138
Latin America and the Carribbean
132
Myanmar / Burma
129
Liberia
125
Bangladesh
116
Syria
111
Zambia
111
Tanzania
100
Malawi
99
Africa
94
Ghana
93
Rwanda
89
Ukraine
85
Congo, Democratic Republic of
66
Philippines
65
South Sudan
60
South–East Asia Region
58
Indonesia
52
Namibia
51
Lesotho
50
Venezuela
49
Cambodia
47
Asia
47
Eastern Europe
47
Mozambique
43
Yemen
43
Zimbabwe
42
West and Central Africa
41
Guinea
37
East and Southern Africa
37
Middle East and North Africa
36
Germany
35
Brazil
35
Haiti
34
Colombia
31
Senegal
31
Eastern Europe and Central Asia
30
Botswana
29
Russia
26
Cameroon
25
Afghanistan
24
Pakistan
24
Burkina Faso
23
Central African Republic
23
Eswatini/ Swaziland
21
Western Pacific Region
20
Lebanon
20
Sudan
20
Thailand
17
Jordan
17
Vietnam
16
Somalia
16
Moldova
15
Tajikistan
14
Laos
14
Iraq
14
China
13
Albania
13
Georgia
12
Mali
12
Turkey
10
North America
10
Peru
9
USA
9
Papua New Guinea
9
Sri Lanka
9
Iran
8
Paraguay
8
Bolivia
8
Palestine
8
Angola
8
Chile
7
Greece
7
Poland
7
Libya
7
Madagascar
7
North Macedonia
6
Mexico
6
Hungary
6
Jamaica
6
Côte d’Ivoire / Ivory Coast
6
Argentina
6
Benin
5
Kyrgyzstan
5
Niger
5
Armenia
5
Guinea-Bissau
5
Turkmenistan
5
Portugal
5
Southern Africa
5
Egypt
5
Romania
5
Ecuador
5
Timor Leste/ East Timor
4
El Salvador
4
Serbia
4
Gambia
4
Kazakhstan
4
Uzbekistan
4
Italy
4
United Kingdom
4
Spain
4
Chad
4
Canada
3
Burundi
3
Malaysia
3
Croatia
3
Saudi Arabia
3
Japan
3
Belarus
3
Bosnia and Herzegovina
3
Honduras
3
Bhutan
3
Guatemala
3
Fiji
2
Singapore
2
Estonia
2
Morocco
2
Bulgaria
2
Lithuania
2
Mauritius
2
Tunisia
2
Azerbaijan
2
Nicaragua
2
Djibouti
2
Slovakia
2
North Korea
1
Switzerland
1
Australia
1
Togo
1
Vanuatu
1
Mongolia
1
Qatar
1
Mauritania
1
Dominican Republic
1
Ireland
1
Gabon
1
Denmark
1
Belgium
1
Norway
1
South Korea
1
French Guyana
1
Israel
1
Solomon Islands
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
2719
Key Resources
559
Clinical Guidelines
554
Women & Child Health
472
Public Health
431
Capacity Building
161
Pharmacy & Technologies
79
Annual Report MEDBOX
3
Toolboxes
COVID-19
665
Mental Health
662
HIV
660
Disability
450
TB
351
Planetary Health
319
Conflict
274
Caregiver
222
Rapid Response
215
Refugee
209
NTDs
205
AMR
198
Ebola & Marburg
177
Global Health Education
170
Pharmacy
126
Natural Hazards
115
Health Financing Toolbox
90
NCDs
84
Social Ethics
51
Specific Hazards
47
Zika
45
Cholera
35
Polio
31
Malaria
12
Typhoon
3
South Sudan
2
This guideline provides updated, evidence-informed guidance on the percentage of total fat in the diet to reduce the risk of unhealthy weight gain.
This guideline is intended for a wide audience involved in the development, design and implementation of policies and programmes in nutrition and pub...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
The objective of this manual is to guide managers of schistosomiasis and soil-transmitted helminthiases control programmes towards the elimination of these diseases as public health problems informed by evidence generated through monitoring and evaluation of these programmes. The manual complements ...
The present guidelines incorporate all these changes, leading to a substantial reconfiguration of therapeutic choices for both disease forms.
HAT is a serious, life-threatening disease and the efficacy of fexinidazole depends on swallowing the medicine after an appropriate intake of food as well as...
Sexual exploitation, sexual abuse and sexual harassment (SEAH) violate the rights and wellbeing of the people we serve and the people with whom we serve. Such behaviours are directly in opposition to WHO’s values and our abiding responsibility to do no harm. WHO uses the umbrella term “sexual mi...
WHO guidelines on meningitis diagnosis, treatment and care. Web Annex C. Evidence-to-Decision frameworks
recommended
New
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
Good primary care may lead to fewer avoidable hospitalizations, but unsafe primary care can cause avoidable illness and injury, leading to unnecessary hospitalizations, and in some cases, disability and even death.Implementing system changes and practices are crucial to improve safety at all levels ...
Report of the Office of the United Nations High Commissioner for Human Rights | The present study focuses on inclusive education as a means to realize the universal right to education, including for persons with disabilities. It analyses the relevant provisions of the Convention on the Rights of Per...
Facing the COVID-19 (new coronavirus disease) pandemic, the countries of the world must take decisive action to stop the spread of the virus. In these critical circumstances, it is es- sential that everyone is informed about other health risks and hazards so that they can stay safe and healthy.
The...
2nd edition .
This Framework applies to the sharing of H5N1 and other influenza viruses with human pandemic potential and the sharing of benefits. This Framework does not apply to seasonal influenza viruses or other non-influenza pathogens or biological substances that may be contained in clinical ...
The far-reaching impacts of the COVID-19 pandemic underscore the critical need for evidence-informed, transparent and inclusive decision-making. Policy-makers have grappled with complex choices amidst uncertainty. They have constantly reassessed response measures while navigating their economic impl...
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti...
This document aims to support those working in primary care to strengthen IPC, informed by existing WHO IPC guidance and implementation resources. Many of the existing WHO IPC guidance and implementation resources initially developed for acute health care facilities have a potential utility for IPC ...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
The Interim Guidance for Risk Communication and Community Engagement (RCCE) outlines recommendations, considerations and methods to raise awareness, manage risk perception, maintain trust and proactively support people at risk to make informed decisions to protect themselves and others from monkeypo...
This training module is designed to equip health workers (HWs) with
knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus
(HPV) vaccine.
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China.
19 March 2020
